Binding study of semotiadil and levosemotiadil with α1-acid glycoprotein using high-performance frontal analysis

Analytical Biochemistry

Volumn 274, Issue 1, 1999, Pages 27-33

  Rodriguez Rosas, Maria Esther ^a   Shibukawa, Akimasa ^a   Yoshikawa, Yuki ^a   Kuroda, Yukihiro ^a   Nakagawa, Terumichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

High performance frontal analysis; Levosemotiadil; Protein binding; Semotiadil; 1 acid glycoprotein

Indexed keywords

BINDING ENERGY; BIOCHEMISTRY; ENANTIOMERS;

ALPHA-1-ACID GLYCOPROTEIN; ALPHA-1-ACID GLYCOPROTEINS (AGP); BINDING AFFINITIES; COMPETITIVE BINDING; FRONTAL ANALYSIS; LEVOSEMOTIADIL; PROTEIN BINDING; SEMOTIADIL;

GLYCOPROTEINS;

CALCIUM CHANNEL BLOCKING AGENT; LEVOSEMOTIADIL; OROSOMUCOID; SESAMODIL FUMARATE; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CALIBRATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENANTIOMER; HIGH PERFORMANCE FRONTAL ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SCATCHARD PLOT; STEREOCHEMISTRY;

EID: 0002874644     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1999.4266     Document Type: Article

References (43)

1. Bacchus H. Cancer. 18:1965;1285-1291.
2. Martyn J. A., Abernethy D. R., Greenblatt D. J. Clin. Pharmacol. Ther. 35:1984;535-540.
3. Kremer J. M., Wilting J., Janssen L. H. Pharmacol. Rev. 40:1988;1-47.
4. Shumid K. The Plasma Proteins: Structure Function and Genetic Control. 1975;Academic Press, New York. p. 184-228.
5. Tucker G. T., Lennard M. S. Pharmacol. Ther. 45:1989;309-329.
6. Noctor T. Wainer I. W. Drug Stereochemistry. 1993;Dekker, New York.
7. Brodie B. B., Kurtz H., Schanker L. J. J. Pharmcol. Exp. Ther. 130:1960;20-25.
8. Mayer M. C., Gultman D. E. J. Pharm. Sci. 57:1968;895-918.
9. Vallner J. V. J. Pharm. Sci. 66:1977;447-465.
10. Kwong T. C. Clin. Chem. Acta. 151:1985;193-216.
11. Oravcova J., Bohs B., Lindner W. J. Chromatogr. 677:1996;1-28.
12. Shibukawa A., Nakagawa T., Nishimura N., Miyake M., Tanaka H. Chem. Pharm. Bull. 37:1989;702-706.
13. Shibukawa A., Nishimura N., Nomura K., Kuroda Y., Nakagawa T. Chem. Pharm. Bull. 38:1990;443-447.
14. Shibukawa A., Nagao M., Kuroda Y., Nakagawa T. Anal. Chem. 62:1990;712-716.
15. Nishimura N., Shibukawa A., Nakagawa T. Anal. Sci. 6:1990;355-359.
16. Shibukawa A., Terakita A., He J., Nakagawa T. J. Pharm. Sci. 81:1992;710-715.
17. Terakita A., Shibukawa A., Nakagawa T. Anal. Sci. 9:1993;229-232.
18. Shibukawa A., Nagao M., Terakita A., He J., Nakagawa T. J. Liq. Chromatogr. 16:1993;903-914.
19. Shibukawa A., Nakao C., Sawada T., Terakita T., Morokoshi N., Nakagawa T. J. Pharm. Sci. 83:1994;868-873.
20. Terakita A., Shibukawa A., Nakagawa T. Anal. Sci. 10:1994;11-15.
21. Shibukawa A., Kadohara M., He J., Nishimura M., Naito S., Nakagawa T. J. Chromatogr. A. 694:1995;81-89.
22. Shibukawa A., Sawada T., Nakao C., Izumi T., Nakagawa T. J. Chromatogr. A. 697:1995;337-343.
23. Shibukawa A., Nakagawa T. Anal. Chem. 68:1996;447-454.
24. He J., Shibukawa A., Tokunaga S., Nakagawa T. J. Pharm. Sci. 86:1997;120-125.
25. Rodriguez Rosas M. E., Shibukawa A., Ueda K., Nakagawa T. J. Pharm. Biomed. Anal. 15:1997;1595-1601.
26. Stark G., Kasper K., Stark U., Miyawaki N., Decrinis M., Tritthart H. A. Eur. J. Pharmacol. 286:1995;71-78.
27. Kageyama M., Yanagisawa T., Taira N. Br. J. Pharmacol. 114:1995;1289-1295.
28. Miyawaki N., Furuta T., Shigei T., Yamauchi H., Iso T. J. Cardiovasc. Pharmacol. 16:1990;769-775.
29. Teramoto N. Jpn. J. Pharmacol. 61:1993;183-195.
30. Nishimura K., Miyawaki N., Yamauchi H., Iso T. Arzneimittelforschung. 40:1990;244-248.
31. Kageyama M., Nishimura K., Takada T., Miyawaki N., Yamauchi H. J. Cardiovasc. Pharmacol. 17:1991;102-107.
32. Takada T., Miyawaki N., Kageyama M., Matsuno K., Ishida N., Yamauchi H., Iso T. J. Cardiovasc. Pharmacol. 18:1991;855-862.
33. Mori T., Irie K., Ashida S. Jpn. J. Pharmacol. 55:1991;328.
34. Mori T., Irie K., Ishii F., Ashida S. Jpn. J. Pharmacol. 52:1990;203.
35. Kodama I., Suzuki R., Maruyama K., Toyama J. Br. J. Pharmacol. 114:1995;503-509.
36. Nakayama K., Morimoto K., Nazawa Y., Tanaka Y. J. Cardiovasc. Pharmacol. 20:1992;380-391.
37. Miyawaki N., Yamazaki F., Furuta T., Shigei T., Yamauchi H. Drug Dev. Res. 22:1991;293-298.
38. Nagashima S., Uematsu T., Araki T., Matsuzaki M., Fukuchi H., Nakashima M. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;688-695.
39. Hirasawa A., Haruno A., Matsuzaki T., Hashimoto K. Jpn. Heart J. 33:1992;851-861.
40. Fukuchi M., Uematsu T., Nagashima S., Nakashima M. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;557-564.
41. Hara Y., Nakaya H. Br. J. Pharmacol. 116:1995;2750-2756.
42. Herve F., Duche J. C., d'Athis P., Marche C., Barre J., Tillement J. P. Pharmacogenetics. 6:1996;403-415.
43. Rodriguez Rosas M. E., Shibukawa A., Yoshikawa Y., Kuroda Y., Nakagawa T. Anal. Sci. 1999.